Skip to content
healthcare.dev

MAYZENT

NDC 0078-0979, siponimod, tablet, film coated, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0979
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209884
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0979 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SIPONIMOD.25 mg/1

Pharmacologic classes

Sphingosine 1-Phosphate Receptor Modulators [MoA]; Sphingosine 1-phosphate Receptor Modulator [EPC]

Package NDCNDC-11Package
0078-0979-120007809791212 TABLET, FILM COATED in 1 BLISTER PACK (0078-0979-12)
0078-0979-500007809795028 TABLET, FILM COATED in 1 BOTTLE (0078-0979-50)
0078-0979-89000780979897 TABLET, FILM COATED in 1 BLISTER PACK (0078-0979-89)
0078-0979-920007809799228 TABLET, FILM COATED in 1 BOTTLE (0078-0979-92)

Linked data

RxNorm, label and prices

Use it

Look up 0078-0979 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0979 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0979. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.